

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interleukin-15 (GO:0071350) | 9.18706772 |
| 2 | activated T cell proliferation (GO:0050798) | 8.98806097 |
| 3 | response to interleukin-15 (GO:0070672) | 8.04339751 |
| 4 | negative regulation of cell killing (GO:0031342) | 7.37214227 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.37214227 |
| 6 | * cellular defense response (GO:0006968) | 6.43803513 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.14121855 |
| 8 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.98393739 |
| 9 | negative thymic T cell selection (GO:0045060) | 5.87485628 |
| 10 | * regulation of natural killer cell mediated immunity (GO:0002715) | 5.61013737 |
| 11 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.61013737 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.55457533 |
| 13 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.52864980 |
| 14 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.52864980 |
| 15 | negative T cell selection (GO:0043383) | 5.37288163 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.35780097 |
| 17 | positive thymic T cell selection (GO:0045059) | 5.08343654 |
| 18 | T cell migration (GO:0072678) | 5.06176425 |
| 19 | positive regulation of isotype switching (GO:0045830) | 4.95592431 |
| 20 | negative regulation of T cell mediated immunity (GO:0002710) | 4.87812905 |
| 21 | regulation of hypersensitivity (GO:0002883) | 4.85380677 |
| 22 | substrate-dependent cell migration (GO:0006929) | 4.79845925 |
| 23 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.78855276 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.74617258 |
| 25 | * natural killer cell activation (GO:0030101) | 4.73620966 |
| 26 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.63530608 |
| 27 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.63530608 |
| 28 | T cell differentiation involved in immune response (GO:0002292) | 4.63530608 |
| 29 | thymic T cell selection (GO:0045061) | 4.62336969 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60764618 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60764618 |
| 32 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.55641886 |
| 33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.38561852 |
| 34 | leukocyte cell-cell adhesion (GO:0007159) | 4.33465651 |
| 35 | heterotypic cell-cell adhesion (GO:0034113) | 4.32173586 |
| 36 | positive regulation of cell killing (GO:0031343) | 4.30573562 |
| 37 | DNA deamination (GO:0045006) | 4.23143045 |
| 38 | T cell activation involved in immune response (GO:0002286) | 4.20622715 |
| 39 | positive regulation of DNA recombination (GO:0045911) | 4.15054640 |
| 40 | * regulation of cell killing (GO:0031341) | 4.09503676 |
| 41 | behavioral response to nicotine (GO:0035095) | 4.08904053 |
| 42 | hypotonic response (GO:0006971) | 4.08333655 |
| 43 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.07716805 |
| 44 | positive regulation of B cell mediated immunity (GO:0002714) | 4.07716805 |
| 45 | leukocyte aggregation (GO:0070486) | 4.06358416 |
| 46 | alpha-beta T cell activation (GO:0046631) | 3.94423609 |
| 47 | endoderm formation (GO:0001706) | 3.90614797 |
| 48 | T cell proliferation (GO:0042098) | 3.87873509 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87294262 |
| 50 | lymphocyte migration (GO:0072676) | 3.78012618 |
| 51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76117493 |
| 52 | alpha-beta T cell differentiation (GO:0046632) | 3.69894406 |
| 53 | regulation of alkaline phosphatase activity (GO:0010692) | 3.68601038 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67739370 |
| 55 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.64423450 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.63393836 |
| 57 | regulation of response to interferon-gamma (GO:0060330) | 3.62259622 |
| 58 | mast cell activation (GO:0045576) | 3.62017799 |
| 59 | positive T cell selection (GO:0043368) | 3.60511249 |
| 60 | L-fucose catabolic process (GO:0042355) | 3.57033967 |
| 61 | fucose catabolic process (GO:0019317) | 3.57033967 |
| 62 | L-fucose metabolic process (GO:0042354) | 3.57033967 |
| 63 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.53080997 |
| 64 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.51962334 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.51936374 |
| 66 | T-helper cell differentiation (GO:0042093) | 3.51919188 |
| 67 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.51919188 |
| 68 | T cell selection (GO:0045058) | 3.50325094 |
| 69 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.50069733 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.49121927 |
| 71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.46408768 |
| 72 | skin morphogenesis (GO:0043589) | 3.44591950 |
| 73 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.41160556 |
| 74 | positive regulation of defense response to virus by host (GO:0002230) | 3.39466864 |
| 75 | leukocyte tethering or rolling (GO:0050901) | 3.38078651 |
| 76 | mast cell activation involved in immune response (GO:0002279) | 3.34955175 |
| 77 | mast cell degranulation (GO:0043303) | 3.34955175 |
| 78 | regulation of memory T cell differentiation (GO:0043380) | 3.34952076 |
| 79 | regulation of isotype switching (GO:0045191) | 3.31942745 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.29969316 |
| 81 | rRNA catabolic process (GO:0016075) | 3.29521741 |
| 82 | negative regulation of telomere maintenance (GO:0032205) | 3.28630402 |
| 83 | positive regulation of interferon-gamma production (GO:0032729) | 3.27978761 |
| 84 | negative regulation of oxidoreductase activity (GO:0051354) | 3.24807402 |
| 85 | T cell costimulation (GO:0031295) | 3.24292995 |
| 86 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.22467789 |
| 87 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.21440105 |
| 88 | negative regulation of interleukin-1 production (GO:0032692) | 3.20961053 |
| 89 | lymphocyte costimulation (GO:0031294) | 3.16400731 |
| 90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15651154 |
| 91 | neutrophil activation (GO:0042119) | 3.14145317 |
| 92 | adaptation of signaling pathway (GO:0023058) | 3.12827078 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 3.10528378 |
| 94 | cytidine deamination (GO:0009972) | 3.10396729 |
| 95 | cytidine metabolic process (GO:0046087) | 3.10396729 |
| 96 | cytidine catabolic process (GO:0006216) | 3.10396729 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 3.06621242 |
| 98 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.06066313 |
| 99 | T cell differentiation (GO:0030217) | 3.05659280 |
| 100 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.03548417 |
| 101 | negative regulation of mast cell activation (GO:0033004) | 3.02864719 |
| 102 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.02053851 |
| 103 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.01871103 |
| 104 | positive regulation of immunoglobulin production (GO:0002639) | 2.99922608 |
| 105 | growth hormone receptor signaling pathway (GO:0060396) | 2.99417799 |
| 106 | cell wall macromolecule metabolic process (GO:0044036) | 2.98104013 |
| 107 | response to protozoan (GO:0001562) | 2.95533604 |
| 108 | cell adhesion mediated by integrin (GO:0033627) | 2.95436712 |
| 109 | cortical actin cytoskeleton organization (GO:0030866) | 2.94819627 |
| 110 | regulation of mesoderm development (GO:2000380) | 2.94763919 |
| 111 | regulation of B cell mediated immunity (GO:0002712) | 2.93303260 |
| 112 | platelet dense granule organization (GO:0060155) | 2.92355303 |
| 113 | granulocyte activation (GO:0036230) | 2.92121018 |
| 114 | protein polyglutamylation (GO:0018095) | 2.89500001 |
| 115 | tolerance induction (GO:0002507) | 2.89227682 |
| 116 | kynurenine metabolic process (GO:0070189) | 2.86888058 |
| 117 | positive regulation of humoral immune response (GO:0002922) | 2.86522452 |
| 118 | tryptophan catabolic process (GO:0006569) | 2.86269425 |
| 119 | indole-containing compound catabolic process (GO:0042436) | 2.86269425 |
| 120 | indolalkylamine catabolic process (GO:0046218) | 2.86269425 |
| 121 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.85407335 |
| 122 | T cell receptor signaling pathway (GO:0050852) | 2.83995443 |
| 123 | cellular extravasation (GO:0045123) | 2.83373637 |
| 124 | cell wall macromolecule catabolic process (GO:0016998) | 2.82738112 |
| 125 | dendritic cell chemotaxis (GO:0002407) | 2.80808452 |
| 126 | hepatocyte apoptotic process (GO:0097284) | 2.80588568 |
| 127 | * regulation of leukocyte mediated immunity (GO:0002703) | 2.80470376 |
| 128 | dendritic cell migration (GO:0036336) | 2.80236483 |
| 129 | sequestering of actin monomers (GO:0042989) | 2.79627744 |
| 130 | multicellular organism reproduction (GO:0032504) | 2.77874724 |
| 131 | chaperone-mediated protein transport (GO:0072321) | 2.75420488 |
| 132 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.74791756 |
| 133 | regulation of T-helper 1 type immune response (GO:0002825) | 2.74027198 |
| 134 | sulfation (GO:0051923) | 2.71313474 |
| 135 | protein-cofactor linkage (GO:0018065) | 2.70612358 |
| 136 | regulation of germinal center formation (GO:0002634) | 2.70028479 |
| 137 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.68729403 |
| 138 | GPI anchor metabolic process (GO:0006505) | 2.67652007 |
| 139 | regulation of activation of Janus kinase activity (GO:0010533) | 2.64452675 |
| 140 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.61499942 |
| 141 | regulation of regulatory T cell differentiation (GO:0045589) | 2.60580108 |
| 142 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.60241789 |
| 143 | head development (GO:0060322) | 2.58537211 |
| 144 | adenosine metabolic process (GO:0046085) | 2.57362648 |
| 145 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.56613276 |
| 146 | indolalkylamine metabolic process (GO:0006586) | 2.56315201 |
| 147 | neural tube formation (GO:0001841) | 2.56121217 |
| 148 | cellular ketone body metabolic process (GO:0046950) | 2.55321429 |
| 149 | sleep (GO:0030431) | 2.55050568 |
| 150 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.52134331 |
| 151 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.51763860 |
| 152 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.50679861 |
| 153 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.49721653 |
| 154 | axoneme assembly (GO:0035082) | 2.46810349 |
| 155 | RNA destabilization (GO:0050779) | 2.46405543 |
| 156 | protein K11-linked deubiquitination (GO:0035871) | 2.45209851 |
| 157 | rhodopsin mediated signaling pathway (GO:0016056) | 2.44688052 |
| 158 | leukocyte degranulation (GO:0043299) | 2.40599951 |
| 159 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.40415681 |
| 160 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.40415681 |
| 161 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.39956758 |
| 162 | regulation of DNA methylation (GO:0044030) | 2.39575067 |
| 163 | lysosome localization (GO:0032418) | 2.38995086 |
| 164 | neurofilament cytoskeleton organization (GO:0060052) | 2.38441940 |
| 165 | regulation of defense response to virus by host (GO:0050691) | 2.38348709 |
| 166 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37980262 |
| 167 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37980262 |
| 168 | interferon-gamma production (GO:0032609) | 14.0488241 |
| 169 | cytolysis (GO:0019835) | 12.1141590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.45059504 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.56115827 |
| 3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.52955463 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.23291011 |
| 5 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.85983956 |
| 6 | MYB_26560356_Chip-Seq_TH2_Human | 3.34135074 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.27481650 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.25912723 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.17839591 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15636100 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.07299160 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.05860824 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98171330 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96848715 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.93442588 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.84214146 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.78584717 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.77159248 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.71805416 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.54644645 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52431739 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52267774 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.50477457 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48457780 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48098932 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.46461317 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44186082 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43971265 |
| 29 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.43463599 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38811766 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31567624 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27004302 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25394276 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23381894 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22959865 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17149260 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07945421 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07028587 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06269092 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04456324 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.01306692 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01228113 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.00803220 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00064419 |
| 45 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99584722 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.98633834 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.95955165 |
| 48 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.90685264 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90591202 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87207639 |
| 51 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.83691288 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79370669 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.75296749 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73490946 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71922299 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70253435 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69682490 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.69137105 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67679432 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61265742 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60018481 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59072474 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58739109 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.56772859 |
| 65 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55365780 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55154337 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55095787 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52799195 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50948079 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.49566817 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48604424 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48604424 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.48310484 |
| 74 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47742536 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47579383 |
| 76 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.47564578 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46131218 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45376949 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44582889 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40856962 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.37992115 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.37992115 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36784577 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36715650 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36675253 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35284701 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34306501 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31941385 |
| 89 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31266948 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28839030 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28230494 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27169154 |
| 93 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27046377 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27013995 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26850577 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26314114 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26119095 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25210360 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23758350 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22091222 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.21893610 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21408187 |
| 103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19937484 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19714751 |
| 105 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.19455180 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18842345 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18329873 |
| 108 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.16177022 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15753174 |
| 110 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15351598 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14508878 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14043447 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14026473 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13046935 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12665637 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12665637 |
| 117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12341196 |
| 118 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12341196 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.11627818 |
| 120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11616347 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.11542738 |
| 122 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10730711 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10507599 |
| 124 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.10234460 |
| 125 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10020251 |
| 126 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09977237 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09828070 |
| 128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09368926 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09240602 |
| 130 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09230059 |
| 131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08588109 |
| 132 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08225239 |
| 133 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08217177 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08193326 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.08190589 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07927701 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07346166 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05586466 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04927967 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04668118 |
| 141 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04621531 |
| 142 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04055028 |
| 143 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03949702 |
| 144 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03618030 |
| 145 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.03471552 |
| 146 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03281442 |
| 147 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02630302 |
| 148 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02170926 |
| 149 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01608768 |
| 150 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01021958 |
| 151 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00572659 |
| 152 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00204268 |
| 153 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.00024624 |
| 154 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99974301 |
| 155 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99442980 |
| 156 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99005600 |
| 157 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98536506 |
| 158 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98239355 |
| 159 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97944700 |
| 160 | GATA3_26560356_Chip-Seq_TH1_Human | 0.97873987 |
| 161 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92976066 |
| 162 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92504098 |
| 163 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92185657 |
| 164 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90545019 |
| 165 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89859826 |
| 166 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.88592310 |
| 167 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88323668 |
| 168 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85514918 |
| 169 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82859553 |
| 170 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81008753 |
| 171 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80543064 |
| 172 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77548696 |
| 173 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77245935 |
| 174 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74953418 |
| 175 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74953418 |
| 176 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73269010 |
| 177 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72245127 |
| 178 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71755480 |
| 179 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69553323 |
| 180 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69369466 |
| 181 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.69058020 |
| 182 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.68142487 |
| 183 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.67606048 |
| 184 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66975555 |
| 185 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66514655 |
| 186 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65386299 |
| 187 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64568893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 6.90818606 |
| 2 | MP0005671_abnormal_response_to | 6.77695944 |
| 3 | MP0009785_altered_susceptibility_to | 3.85895266 |
| 4 | MP0003448_altered_tumor_morphology | 3.41754362 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.38490858 |
| 6 | MP0008877_abnormal_DNA_methylation | 3.26118120 |
| 7 | MP0001800_abnormal_humoral_immune | 3.24029442 |
| 8 | MP0010307_abnormal_tumor_latency | 3.12289833 |
| 9 | MP0003787_abnormal_imprinting | 2.95964413 |
| 10 | * MP0005025_abnormal_response_to | 2.88166690 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.80624896 |
| 12 | MP0000858_altered_metastatic_potential | 2.79691721 |
| 13 | MP0002723_abnormal_immune_serum | 2.74312174 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.73715543 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.67264920 |
| 16 | MP0003195_calcinosis | 2.67212165 |
| 17 | * MP0001819_abnormal_immune_cell | 2.64217128 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.55861110 |
| 19 | MP0002132_abnormal_respiratory_system | 2.53955280 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.45753309 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.39469718 |
| 22 | MP0005387_immune_system_phenotype | 2.33518515 |
| 23 | MP0001790_abnormal_immune_system | 2.33518515 |
| 24 | MP0000685_abnormal_immune_system | 2.26385951 |
| 25 | MP0006292_abnormal_olfactory_placode | 2.25063038 |
| 26 | MP0008995_early_reproductive_senescence | 2.24614647 |
| 27 | MP0001873_stomach_inflammation | 2.19675568 |
| 28 | MP0002006_tumorigenesis | 2.19125360 |
| 29 | MP0002398_abnormal_bone_marrow | 2.16800916 |
| 30 | MP0005377_hearing/vestibular/ear_phenot | 2.16708126 |
| 31 | MP0003878_abnormal_ear_physiology | 2.16708126 |
| 32 | MP0003300_gastrointestinal_ulcer | 2.03147904 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 2.02709769 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 2.02336947 |
| 35 | MP0002102_abnormal_ear_morphology | 1.99218218 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.98927310 |
| 37 | MP0003724_increased_susceptibility_to | 1.93755643 |
| 38 | MP0002405_respiratory_system_inflammati | 1.91395548 |
| 39 | * MP0000716_abnormal_immune_system | 1.90673721 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.88621223 |
| 41 | MP0002722_abnormal_immune_system | 1.86719995 |
| 42 | MP0002419_abnormal_innate_immunity | 1.84270239 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.82351728 |
| 44 | MP0008872_abnormal_physiological_respon | 1.79905779 |
| 45 | MP0004142_abnormal_muscle_tone | 1.77026820 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.76628028 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.74817968 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.74412551 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.74128045 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.72498347 |
| 51 | MP0004947_skin_inflammation | 1.72369657 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.72367503 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.70074536 |
| 54 | MP0008469_abnormal_protein_level | 1.66212833 |
| 55 | MP0002254_reproductive_system_inflammat | 1.65155667 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.64751279 |
| 57 | MP0003866_abnormal_defecation | 1.60608654 |
| 58 | MP0003646_muscle_fatigue | 1.57153784 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.54879790 |
| 60 | MP0003436_decreased_susceptibility_to | 1.53172982 |
| 61 | MP0002736_abnormal_nociception_after | 1.52909924 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.51990952 |
| 63 | MP0004885_abnormal_endolymph | 1.50737160 |
| 64 | * MP0002429_abnormal_blood_cell | 1.50562949 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.46703975 |
| 66 | MP0000920_abnormal_myelination | 1.41575844 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.38468144 |
| 68 | MP0003303_peritoneal_inflammation | 1.38002503 |
| 69 | MP0001851_eye_inflammation | 1.36859649 |
| 70 | MP0002163_abnormal_gland_morphology | 1.36450139 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.33610824 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.28425740 |
| 73 | MP0009763_increased_sensitivity_to | 1.27047252 |
| 74 | MP0003011_delayed_dark_adaptation | 1.26681411 |
| 75 | MP0004043_abnormal_pH_regulation | 1.24178554 |
| 76 | MP0003786_premature_aging | 1.23036463 |
| 77 | MP0004133_heterotaxia | 1.22407344 |
| 78 | MP0001919_abnormal_reproductive_system | 1.20491755 |
| 79 | MP0004510_myositis | 1.19280535 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 1.18034249 |
| 81 | MP0002933_joint_inflammation | 1.16024368 |
| 82 | MP0009384_cardiac_valve_regurgitation | 1.13401570 |
| 83 | MP0002638_abnormal_pupillary_reflex | 1.12823400 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 1.12737010 |
| 85 | MP0005389_reproductive_system_phenotype | 1.12495859 |
| 86 | MP0002396_abnormal_hematopoietic_system | 1.11870474 |
| 87 | MP0000343_altered_response_to | 1.11693654 |
| 88 | MP0005253_abnormal_eye_physiology | 1.11412244 |
| 89 | MP0000427_abnormal_hair_cycle | 1.10030788 |
| 90 | MP0002019_abnormal_tumor_incidence | 1.08457506 |
| 91 | MP0001485_abnormal_pinna_reflex | 1.07085043 |
| 92 | MP0002928_abnormal_bile_duct | 1.05523483 |
| 93 | MP0001533_abnormal_skeleton_physiology | 1.05118111 |
| 94 | MP0004147_increased_porphyrin_level | 1.03037581 |
| 95 | MP0005174_abnormal_tail_pigmentation | 1.02647939 |
| 96 | MP0004381_abnormal_hair_follicle | 1.02294037 |
| 97 | MP0009745_abnormal_behavioral_response | 1.01732205 |
| 98 | MP0001501_abnormal_sleep_pattern | 1.01310433 |
| 99 | MP0003566_abnormal_cell_adhesion | 1.01191409 |
| 100 | MP0004742_abnormal_vestibular_system | 1.00577889 |
| 101 | MP0003121_genomic_imprinting | 0.98935234 |
| 102 | MP0002272_abnormal_nervous_system | 0.98927825 |
| 103 | MP0005166_decreased_susceptibility_to | 0.96744923 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.96692987 |
| 105 | MP0009764_decreased_sensitivity_to | 0.96634728 |
| 106 | MP0000490_abnormal_crypts_of | 0.96567777 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.96262322 |
| 108 | MP0005645_abnormal_hypothalamus_physiol | 0.95068524 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 0.94452206 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.93538549 |
| 111 | MP0001984_abnormal_olfaction | 0.93280521 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.92053359 |
| 113 | MP0000604_amyloidosis | 0.89555117 |
| 114 | MP0001486_abnormal_startle_reflex | 0.89481682 |
| 115 | MP0003880_abnormal_central_pattern | 0.89290750 |
| 116 | MP0005310_abnormal_salivary_gland | 0.88365584 |
| 117 | MP0003252_abnormal_bile_duct | 0.87540072 |
| 118 | MP0000609_abnormal_liver_physiology | 0.85166889 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.84552018 |
| 120 | MP0003329_amyloid_beta_deposits | 0.83062800 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.80930156 |
| 122 | MP0008873_increased_physiological_sensi | 0.80824602 |
| 123 | MP0001545_abnormal_hematopoietic_system | 0.80684280 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.80684280 |
| 125 | MP0003119_abnormal_digestive_system | 0.79693804 |
| 126 | MP0001119_abnormal_female_reproductive | 0.78252934 |
| 127 | MP0001853_heart_inflammation | 0.77966985 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.75515558 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.75417807 |
| 130 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72411272 |
| 131 | MP0003122_maternal_imprinting | 0.71532291 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.69138652 |
| 133 | MP0003136_yellow_coat_color | 0.68725176 |
| 134 | MP0005195_abnormal_posterior_eye | 0.68690826 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.68548760 |
| 136 | MP0002557_abnormal_social/conspecific_i | 0.68369303 |
| 137 | MP0000631_abnormal_neuroendocrine_gland | 0.67474926 |
| 138 | MP0003690_abnormal_glial_cell | 0.64865310 |
| 139 | MP0004883_abnormal_blood_vessel | 0.64796880 |
| 140 | MP0003091_abnormal_cell_migration | 0.61501341 |
| 141 | MP0001727_abnormal_embryo_implantation | 0.61235421 |
| 142 | MP0004130_abnormal_muscle_cell | 0.58406728 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.57868453 |
| 144 | MP0003075_altered_response_to | 0.57640785 |
| 145 | MP0003890_abnormal_embryonic-extraembry | 0.56766796 |
| 146 | MP0009278_abnormal_bone_marrow | 0.56728358 |
| 147 | MP0000249_abnormal_blood_vessel | 0.56478620 |
| 148 | MP0005023_abnormal_wound_healing | 0.53994091 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53684913 |
| 150 | MP0000613_abnormal_salivary_gland | 0.52227895 |
| 151 | MP0003453_abnormal_keratinocyte_physiol | 0.51390614 |
| 152 | MP0006054_spinal_hemorrhage | 0.51029059 |
| 153 | MP0002138_abnormal_hepatobiliary_system | 0.50244130 |
| 154 | MP0002693_abnormal_pancreas_physiology | 0.46777133 |
| 155 | MP0009840_abnormal_foam_cell | 0.45310211 |
| 156 | MP0002877_abnormal_melanocyte_morpholog | 0.42773802 |
| 157 | MP0003045_fibrosis | 0.42489015 |
| 158 | MP0001663_abnormal_digestive_system | 0.41971865 |
| 159 | MP0005360_urolithiasis | 0.41060802 |
| 160 | MP0002136_abnormal_kidney_physiology | 0.41007568 |
| 161 | MP0003705_abnormal_hypodermis_morpholog | 0.40877441 |
| 162 | MP0005386_behavior/neurological_phenoty | 0.39719325 |
| 163 | MP0004924_abnormal_behavior | 0.39719325 |
| 164 | MP0005076_abnormal_cell_differentiation | 0.39097761 |
| 165 | MP0002086_abnormal_extraembryonic_tissu | 0.37185746 |
| 166 | MP0009642_abnormal_blood_homeostasis | 0.36874685 |
| 167 | MP0008874_decreased_physiological_sensi | 0.35662019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hemiplegia (HP:0002301) | 8.36672072 |
| 2 | Hypoproteinemia (HP:0003075) | 7.57779498 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 6.85850927 |
| 4 | Optic neuritis (HP:0100653) | 6.85850927 |
| 5 | Encephalitis (HP:0002383) | 6.72974442 |
| 6 | Orchitis (HP:0100796) | 6.26767193 |
| 7 | Tetraplegia (HP:0002445) | 6.22160908 |
| 8 | Myositis (HP:0100614) | 6.11531203 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 5.90042804 |
| 10 | Increased serum ferritin (HP:0003281) | 5.75752662 |
| 11 | Nasal polyposis (HP:0100582) | 5.59788153 |
| 12 | Abnormality of macrophages (HP:0004311) | 5.51866044 |
| 13 | Increased CSF protein (HP:0002922) | 5.23170485 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 4.96000955 |
| 15 | Abnormality of iron homeostasis (HP:0011031) | 4.91653727 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 4.71514989 |
| 17 | Abnormal albumin level (HP:0012116) | 4.61444555 |
| 18 | Hypoalbuminemia (HP:0003073) | 4.61444555 |
| 19 | Meningitis (HP:0001287) | 4.58833899 |
| 20 | Keratoconjunctivitis (HP:0001096) | 4.46383662 |
| 21 | Joint swelling (HP:0001386) | 4.28022855 |
| 22 | Abnormality of transition element cation homeostasis (HP:0011030) | 4.20037250 |
| 23 | T lymphocytopenia (HP:0005403) | 4.02408208 |
| 24 | Stomatitis (HP:0010280) | 4.00971004 |
| 25 | Hyponatremia (HP:0002902) | 3.85991434 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.75253590 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.70925830 |
| 28 | Pancreatic cysts (HP:0001737) | 3.64651019 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.54908423 |
| 30 | IgG deficiency (HP:0004315) | 3.53646624 |
| 31 | Increased intracranial pressure (HP:0002516) | 3.50268789 |
| 32 | Abnormality of intracranial pressure (HP:0012640) | 3.50268789 |
| 33 | Arterial thrombosis (HP:0004420) | 3.48259629 |
| 34 | IgM deficiency (HP:0002850) | 3.45582528 |
| 35 | Pulmonary embolism (HP:0002204) | 3.42765112 |
| 36 | Renal cortical cysts (HP:0000803) | 3.38204785 |
| 37 | Stomach cancer (HP:0012126) | 3.33950621 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 3.32121185 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 3.32121185 |
| 40 | Nephronophthisis (HP:0000090) | 3.25034876 |
| 41 | Abnormality of sodium homeostasis (HP:0010931) | 3.14968593 |
| 42 | Hypertriglyceridemia (HP:0002155) | 3.13776850 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 3.11766559 |
| 44 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.92687018 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.89663617 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.87550677 |
| 47 | Vasculitis (HP:0002633) | 2.87544132 |
| 48 | True hermaphroditism (HP:0010459) | 2.86318063 |
| 49 | Increased IgE level (HP:0003212) | 2.85086279 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.82407043 |
| 51 | Increased density of long bones (HP:0006392) | 2.80593478 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.80195333 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.75797387 |
| 54 | Duplicated collecting system (HP:0000081) | 2.72987774 |
| 55 | Abnormality of the renal collecting system (HP:0004742) | 2.70068121 |
| 56 | Recurrent abscess formation (HP:0002722) | 2.65574420 |
| 57 | Abnormality of the renal medulla (HP:0100957) | 2.63981726 |
| 58 | Chronic hepatic failure (HP:0100626) | 2.63208526 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.54136933 |
| 60 | Hemoptysis (HP:0002105) | 2.52870733 |
| 61 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.50726632 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.50350021 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.47409468 |
| 64 | Gangrene (HP:0100758) | 2.47055170 |
| 65 | Abnormality of T cells (HP:0002843) | 2.46086626 |
| 66 | Abnormality of DNA repair (HP:0003254) | 2.45286833 |
| 67 | Lymphoma (HP:0002665) | 2.43110693 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.41183234 |
| 69 | Anorexia (HP:0002039) | 2.40469819 |
| 70 | Abnormality of B cell number (HP:0010975) | 2.36133026 |
| 71 | Chronic otitis media (HP:0000389) | 2.32718054 |
| 72 | Alveolar cell carcinoma (HP:0006519) | 2.32012850 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.30901781 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.28285036 |
| 75 | Pendular nystagmus (HP:0012043) | 2.26234925 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.25502977 |
| 77 | Colitis (HP:0002583) | 2.25398619 |
| 78 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.24407149 |
| 79 | Hypoplasia of the uterus (HP:0000013) | 2.23656522 |
| 80 | Inability to walk (HP:0002540) | 2.22694361 |
| 81 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.22624485 |
| 82 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.22421105 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.21143810 |
| 84 | Gingival bleeding (HP:0000225) | 2.17625239 |
| 85 | Recurrent viral infections (HP:0004429) | 2.17505436 |
| 86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17330069 |
| 87 | Abnormal pancreas size (HP:0012094) | 2.16481190 |
| 88 | Bile duct proliferation (HP:0001408) | 2.14957193 |
| 89 | Abnormal biliary tract physiology (HP:0012439) | 2.14957193 |
| 90 | Progressive inability to walk (HP:0002505) | 2.14861269 |
| 91 | Asplenia (HP:0001746) | 2.14657686 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.13627265 |
| 93 | Abnormal platelet volume (HP:0011876) | 2.12474346 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11806694 |
| 95 | Periodontitis (HP:0000704) | 2.10051552 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 2.06315293 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.05028801 |
| 98 | Keratitis (HP:0000491) | 2.03580223 |
| 99 | Absent thumb (HP:0009777) | 2.02052719 |
| 100 | Hyperalaninemia (HP:0003348) | 2.00074110 |
| 101 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00074110 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 2.00074110 |
| 103 | Brittle hair (HP:0002299) | 1.99464831 |
| 104 | Glomerulopathy (HP:0100820) | 1.98019058 |
| 105 | Increased IgM level (HP:0003496) | 1.97798608 |
| 106 | Leukocytosis (HP:0001974) | 1.97212918 |
| 107 | Concave nail (HP:0001598) | 1.95302488 |
| 108 | Chest pain (HP:0100749) | 1.95024138 |
| 109 | Arthralgia (HP:0002829) | 1.94393887 |
| 110 | Broad ribs (HP:0000885) | 1.94273838 |
| 111 | Combined immunodeficiency (HP:0005387) | 1.93701524 |
| 112 | Hypochromic anemia (HP:0001931) | 1.93464243 |
| 113 | Thrombophlebitis (HP:0004418) | 1.92274634 |
| 114 | Cystic liver disease (HP:0006706) | 1.91421297 |
| 115 | Papilloma (HP:0012740) | 1.91194493 |
| 116 | Verrucae (HP:0200043) | 1.91194493 |
| 117 | Aortic aneurysm (HP:0004942) | 1.90785731 |
| 118 | Epistaxis (HP:0000421) | 1.89824738 |
| 119 | Abnormality of oral frenula (HP:0000190) | 1.87786619 |
| 120 | Agitation (HP:0000713) | 1.87605775 |
| 121 | Intestinal atresia (HP:0011100) | 1.87081439 |
| 122 | Pustule (HP:0200039) | 1.86271773 |
| 123 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.86049072 |
| 124 | Methylmalonic acidemia (HP:0002912) | 1.85124727 |
| 125 | Autoimmune thrombocytopenia (HP:0001973) | 1.84288747 |
| 126 | Thyroiditis (HP:0100646) | 1.83711161 |
| 127 | Type II lissencephaly (HP:0007260) | 1.83632313 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.82614057 |
| 129 | Abnormality of the ileum (HP:0001549) | 1.80586831 |
| 130 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.80419232 |
| 131 | Striae distensae (HP:0001065) | 1.80238899 |
| 132 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.80133191 |
| 133 | Absent/shortened dynein arms (HP:0200106) | 1.80133191 |
| 134 | Abnormality of eosinophils (HP:0001879) | 1.79690935 |
| 135 | Arterial tortuosity (HP:0005116) | 1.79166246 |
| 136 | Ectopic kidney (HP:0000086) | 1.79087981 |
| 137 | Cellulitis (HP:0100658) | 1.79070421 |
| 138 | Dysostosis multiplex (HP:0000943) | 1.78980255 |
| 139 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.78955074 |
| 140 | Meckel diverticulum (HP:0002245) | 1.78332859 |
| 141 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78260775 |
| 142 | Obstructive lung disease (HP:0006536) | 1.78012690 |
| 143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78012690 |
| 144 | Eosinophilia (HP:0001880) | 1.76938375 |
| 145 | Conical tooth (HP:0000698) | 1.76866620 |
| 146 | Spondylolisthesis (HP:0003302) | 1.76746507 |
| 147 | Mucopolysacchariduria (HP:0008155) | 1.76569811 |
| 148 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76569811 |
| 149 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76082428 |
| 150 | Oligodactyly (hands) (HP:0001180) | 1.75877706 |
| 151 | Septo-optic dysplasia (HP:0100842) | 1.75512439 |
| 152 | Abnormality of the pericardium (HP:0001697) | 1.75440543 |
| 153 | Leukopenia (HP:0001882) | 1.74889872 |
| 154 | Neutropenia (HP:0001875) | 1.74686596 |
| 155 | Polyneuropathy (HP:0001271) | 1.73596900 |
| 156 | Impaired platelet aggregation (HP:0003540) | 1.71960591 |
| 157 | Abnormal platelet function (HP:0011869) | 1.71960591 |
| 158 | Premature skin wrinkling (HP:0100678) | 1.70959714 |
| 159 | Chromsome breakage (HP:0040012) | 1.70763732 |
| 160 | Recurrent bacterial skin infections (HP:0005406) | 1.70582194 |
| 161 | Hyperglycinemia (HP:0002154) | 1.70285499 |
| 162 | Menorrhagia (HP:0000132) | 1.69637171 |
| 163 | Hypomagnesemia (HP:0002917) | 1.69536263 |
| 164 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.69189507 |
| 165 | Anencephaly (HP:0002323) | 1.69015836 |
| 166 | Clubbing of toes (HP:0100760) | 1.68892001 |
| 167 | Abnormal drinking behavior (HP:0030082) | 1.68489814 |
| 168 | Polydipsia (HP:0001959) | 1.68489814 |
| 169 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.68102826 |
| 170 | Increased mean platelet volume (HP:0011877) | 1.68036044 |
| 171 | Severe combined immunodeficiency (HP:0004430) | 1.66901668 |
| 172 | Persistence of primary teeth (HP:0006335) | 1.63476937 |
| 173 | Panhypogammaglobulinemia (HP:0003139) | 1.62899494 |
| 174 | Mediastinal lymphadenopathy (HP:0100721) | 1.56071236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.94599856 |
| 2 | JAK1 | 4.46828096 |
| 3 | MAP4K1 | 3.56793788 |
| 4 | GRK7 | 3.47606483 |
| 5 | ITK | 2.94329801 |
| 6 | STK10 | 2.88470607 |
| 7 | FRK | 2.67423361 |
| 8 | EPHB1 | 2.66865317 |
| 9 | ACVR1B | 2.49727621 |
| 10 | MAP4K2 | 2.48861869 |
| 11 | JAK3 | 2.39410544 |
| 12 | TAOK3 | 2.09224796 |
| 13 | NUAK1 | 2.08064645 |
| 14 | GRK6 | 2.04984692 |
| 15 | FES | 2.02079546 |
| 16 | GRK1 | 1.97184682 |
| 17 | BMPR1B | 1.91772654 |
| 18 | ZAK | 1.91403937 |
| 19 | TLK1 | 1.89904114 |
| 20 | TRIB3 | 1.86649928 |
| 21 | TYK2 | 1.86574929 |
| 22 | WNK3 | 1.81631556 |
| 23 | RIPK1 | 1.79799513 |
| 24 | CSK | 1.75830943 |
| 25 | ADRBK2 | 1.71221658 |
| 26 | MAP3K10 | 1.69926733 |
| 27 | TRIM28 | 1.67164277 |
| 28 | MST4 | 1.60427136 |
| 29 | EEF2K | 1.58724177 |
| 30 | STK24 | 1.58064740 |
| 31 | MUSK | 1.57075255 |
| 32 | PINK1 | 1.51974168 |
| 33 | LRRK2 | 1.43318519 |
| 34 | MAPK13 | 1.42358410 |
| 35 | BCKDK | 1.41246036 |
| 36 | PRKCH | 1.40459193 |
| 37 | SIK3 | 1.40438943 |
| 38 | EPHA3 | 1.38863005 |
| 39 | LCK | 1.37303522 |
| 40 | TTN | 1.37228747 |
| 41 | PRKCQ | 1.35377556 |
| 42 | IRAK3 | 1.35002753 |
| 43 | CASK | 1.30306803 |
| 44 | TNK2 | 1.28534329 |
| 45 | WNK4 | 1.25665431 |
| 46 | BTK | 1.22912350 |
| 47 | ZAP70 | 1.21245846 |
| 48 | PIM1 | 1.19973567 |
| 49 | CDK4 | 1.16677416 |
| 50 | TNIK | 1.16612396 |
| 51 | DAPK2 | 1.13567534 |
| 52 | FGFR3 | 1.12230097 |
| 53 | MAP3K9 | 1.10049292 |
| 54 | MAP2K2 | 1.06566131 |
| 55 | CDK12 | 1.05585983 |
| 56 | SYK | 1.04845896 |
| 57 | FGFR4 | 0.98751194 |
| 58 | OXSR1 | 0.97294272 |
| 59 | MAP3K4 | 0.96368065 |
| 60 | KIT | 0.95872509 |
| 61 | TBK1 | 0.92239201 |
| 62 | SIK2 | 0.89600457 |
| 63 | ADRBK1 | 0.89334919 |
| 64 | BMX | 0.86882914 |
| 65 | TGFBR2 | 0.86715793 |
| 66 | ALK | 0.86458816 |
| 67 | IRAK4 | 0.84145215 |
| 68 | KDR | 0.84002979 |
| 69 | PKN2 | 0.83444852 |
| 70 | PTK6 | 0.82976288 |
| 71 | HCK | 0.82175504 |
| 72 | MAP2K6 | 0.78758215 |
| 73 | MARK3 | 0.77076676 |
| 74 | DMPK | 0.76915217 |
| 75 | JAK2 | 0.76072335 |
| 76 | GSK3A | 0.75930220 |
| 77 | PIK3CG | 0.75090569 |
| 78 | MAP3K2 | 0.74761805 |
| 79 | MATK | 0.71860595 |
| 80 | INSRR | 0.71690778 |
| 81 | ERN1 | 0.69567005 |
| 82 | HIPK2 | 0.68882697 |
| 83 | BLK | 0.67947209 |
| 84 | CDK19 | 0.63449260 |
| 85 | TRPM7 | 0.61351662 |
| 86 | MAP3K14 | 0.60712062 |
| 87 | IGF1R | 0.60443211 |
| 88 | CHUK | 0.59623088 |
| 89 | FGR | 0.59584000 |
| 90 | LYN | 0.59116380 |
| 91 | BCR | 0.58067710 |
| 92 | MELK | 0.56800478 |
| 93 | DYRK2 | 0.56507887 |
| 94 | PAK3 | 0.56256957 |
| 95 | CDK9 | 0.56243712 |
| 96 | MAPK12 | 0.56123064 |
| 97 | MAP3K7 | 0.55790005 |
| 98 | RET | 0.55782666 |
| 99 | RPS6KA4 | 0.55542915 |
| 100 | IKBKE | 0.54072391 |
| 101 | BMPR2 | 0.53165595 |
| 102 | CDK6 | 0.53114857 |
| 103 | TSSK6 | 0.48923009 |
| 104 | STK39 | 0.46704141 |
| 105 | PIK3CA | 0.46236584 |
| 106 | PDK1 | 0.44842142 |
| 107 | PRKG2 | 0.44341634 |
| 108 | PRKCG | 0.44297102 |
| 109 | PRKCE | 0.44277421 |
| 110 | EIF2AK2 | 0.43816362 |
| 111 | CSF1R | 0.42493953 |
| 112 | CLK1 | 0.42390905 |
| 113 | NLK | 0.40793648 |
| 114 | TEC | 0.40258573 |
| 115 | STK16 | 0.39686844 |
| 116 | FYN | 0.39615150 |
| 117 | NME1 | 0.38566748 |
| 118 | PDGFRB | 0.37537228 |
| 119 | MAP2K7 | 0.37339509 |
| 120 | NEK2 | 0.37107922 |
| 121 | SGK3 | 0.37102996 |
| 122 | NTRK3 | 0.36888546 |
| 123 | GRK5 | 0.36732729 |
| 124 | PAK4 | 0.35751390 |
| 125 | CDK8 | 0.34924651 |
| 126 | TGFBR1 | 0.34895642 |
| 127 | CAMK1G | 0.34092408 |
| 128 | INSR | 0.34085487 |
| 129 | NTRK2 | 0.33852747 |
| 130 | TIE1 | 0.32369457 |
| 131 | MAP3K8 | 0.32238660 |
| 132 | MARK1 | 0.32081977 |
| 133 | RIPK4 | 0.31576060 |
| 134 | SCYL2 | 0.31160332 |
| 135 | PRKACA | 0.29357264 |
| 136 | RPS6KA6 | 0.28892154 |
| 137 | PRKCZ | 0.28689004 |
| 138 | CSNK1A1L | 0.28595371 |
| 139 | DYRK3 | 0.28372832 |
| 140 | TYRO3 | 0.28048573 |
| 141 | CSNK1G2 | 0.27929320 |
| 142 | ABL1 | 0.27247409 |
| 143 | MAP2K1 | 0.27071077 |
| 144 | PLK2 | 0.25812907 |
| 145 | PHKG2 | 0.25590021 |
| 146 | PHKG1 | 0.25590021 |
| 147 | MKNK2 | 0.25039267 |
| 148 | MAPK4 | 0.25028863 |
| 149 | CAMK1 | 0.24744441 |
| 150 | MAPKAPK3 | 0.24573319 |
| 151 | PTK2 | 0.24343816 |
| 152 | CSNK1G3 | 0.23723900 |
| 153 | CAMK1D | 0.23484609 |
| 154 | MAP2K3 | 0.23321506 |
| 155 | TESK2 | 0.22690694 |
| 156 | IKBKB | 0.21980713 |
| 157 | CSNK1G1 | 0.21755869 |
| 158 | SIK1 | 0.21743371 |
| 159 | STK11 | 0.21087437 |
| 160 | ILK | 0.21079981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 7.97027109 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.87699242 |
| 3 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.74000865 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.64302868 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.62401394 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.60658897 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 3.17164224 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.08446777 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.78415548 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.74762660 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.51850407 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.37576251 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.36344832 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.25010358 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02453175 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.82173320 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.81516692 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67411286 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.66074420 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61641095 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60407424 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60015943 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54309675 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.53082771 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52263272 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.52211044 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50365754 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.50274167 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49942693 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.47899456 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44894903 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42509558 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42208522 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38908567 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38150712 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36537477 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26633365 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25927740 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23273506 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22628962 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22523032 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.22034843 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.20284514 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20090011 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18078681 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.14565190 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13936892 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13130414 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10856136 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09828743 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.09602613 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08685123 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07785735 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03342095 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.02087253 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99290343 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98631717 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.97747384 |
| 59 | Protein export_Homo sapiens_hsa03060 | 0.97074500 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96646433 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96558920 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92921911 |
| 63 | Homologous recombination_Homo sapiens_hsa03440 | 0.91697848 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88038908 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87604334 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.87429079 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.85935369 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85763863 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84856158 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83165985 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80731682 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.79936770 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79815481 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78458883 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77806583 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77761541 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77735816 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76351948 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76194458 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74982251 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74468852 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73506955 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72463767 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71056693 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.71035585 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.69707546 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.69607215 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69565875 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69505806 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68370917 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67656695 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67147535 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65245193 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.65228246 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65219807 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62484055 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62026360 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61632289 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59364112 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58537365 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57052258 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.57039022 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55839239 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54402223 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.54252882 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53332453 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52697684 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52117916 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.50505017 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50324240 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48025969 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47952369 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47092269 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.46502076 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46411558 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45133795 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44887659 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44813037 |
| 119 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43896622 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.43023568 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.41771820 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41679348 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41467662 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41229788 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40758330 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40087821 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39989280 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39570997 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.37914234 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37391675 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.36301394 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36012048 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.35622462 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35572012 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34768730 |
| 136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34759756 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34707651 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | 0.32944908 |
| 139 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31672600 |
| 140 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31506096 |
| 141 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31356964 |
| 142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30768920 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30491774 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29604384 |
| 145 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29155244 |
| 146 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27663195 |
| 147 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.27583391 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27210106 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26201457 |
| 150 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25706574 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25443940 |
| 152 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25242635 |
| 153 | Glioma_Homo sapiens_hsa05214 | 0.24196464 |
| 154 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22964211 |
| 155 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.22216055 |
| 156 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22135370 |
| 157 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20460791 |
| 158 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19162153 |
| 159 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17081222 |
| 160 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16759640 |
| 161 | Prion diseases_Homo sapiens_hsa05020 | 0.16032499 |
| 162 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15942808 |
| 163 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14166445 |
| 164 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13000052 |
| 165 | Renin secretion_Homo sapiens_hsa04924 | 0.12593450 |
| 166 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.11606188 |
| 167 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.11279797 |
| 168 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10965398 |

